Delivery Order SPE2DR25D1100-SPE2DR26FDE2J

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, with a ceiling value of $3,874.06 for supply of Ingrezza 40 mg capsule, 30-count units.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 4, 2026. Pricing is firm fixed price under a non-set-aside competitive award.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for supply of Ingrezza 80 mg capsules (30-count), with a ceiling value of $4,244.58 under firm fixed-price terms.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is March 3, 2026. No set-aside was used for this order.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $4,267.66 for supply of Ingrezza 60 mg capsule 30s, a pharmaceutical product for federal medical procurement.</p> <p>Place of performance is Conshohocken, Pennsylvania. The order has an ultimate completion date of February 27, 2026, and is priced on a firm fixed-price basis under no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 4, 2026, for INGREZZA 40 mg capsule 30s with a ceiling value of $3,874.06.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 26, 2026. The order is priced firm fixed price with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for INGREZZA 60 mg capsule (30-count) with a ceiling value of $4,267.66.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. The order is priced on a firm fixed-price basis and was issued without a set-aside.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $3,874.06. This is a firm fixed-price delivery order with an ultimate completion date of December 30, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for INGREZZA 80 mg capsule 30-count units, with a ceiling value of $4,244.58.</p> <p>Place of performance is Conshohocken, PA 19428. The ultimate completion date is March 2, 2026. The order is priced on a firm fixed-price basis and uses no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for INGREZZA 80 mg capsule (30-count) with a ceiling value of $8,489.16.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 4, 2026. No set-aside was used.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) with a ceiling value of $11,028.36. This firm fixed-price delivery order, which is neither set-aside nor restricted, represents a competitively awarded procurement supporting federal medical supply needs. The work is scheduled for completion by September 26, 2025, with performance taking place at AmerisourceBergen's corporate office...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count) on November 10, 2025, with a contract ceiling value of $3,676.11 and an ultimate completion date of December 3, 2025. This non-set-aside, competitively awarded delivery order carries firm fixed price terms and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...